Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Upkar S Gill

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Frontline Gastroenterology|July 12, 2021
Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort studyOliver D Tavabie, Jennie N Clough, Jonathan Blackwell, et al.
The Journal of Infectious Diseases|August 27, 2014
Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?Upkar S Gill, Alexandra Zissimopoulos, Safa Al-Shamma, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Preserved CD4 <sup>+</sup> T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapyAljawharah Alrubayyi, Anucha Preechanukul, Yinru Zhang, et al.
JHEP Reports : Innovation in Hepatology|October 24, 2025
Corrigendum to "Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response" [J Hepatol (2025) 101382]Douglas L Fink, David Etoori, Robert Hill, et al.
The Journal of Experimental Medicine|December 21, 2012
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletionDimitra Peppa, Upkar S Gill, Gary Reynolds, et al.
Gut|January 6, 2021
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis BValentina Svicher, Romina Salpini, Lorenzo Piermatteo, et al.
The Lancet Regional Health. Europe|June 10, 2026
From targets to real world impact: a review of models of care for chronic HBV and HCV in EuropeCamila A Picchio, Aina Nicolàs, Erika Duffell, et al.
Scientific Reports|July 19, 2017
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosisHarsimran D Singh, Itziar Otano, Krista Rombouts, et al.
The Journal of Clinical Investigation|August 10, 2018
Circulating and intrahepatic antiviral B cells are defective in hepatitis BAlice R Burton, Laura J Pallett, Laura E McCoy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 30, 2016
T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance SystemWei-Chen Huang, Nicholas J Easom, Xin-Zi Tang, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Frontline Gastroenterology|July 12, 2021
Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort studyOliver D Tavabie, Jennie N Clough, Jonathan Blackwell, et al.
The Journal of Infectious Diseases|August 27, 2014
Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?Upkar S Gill, Alexandra Zissimopoulos, Safa Al-Shamma, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Preserved CD4 <sup>+</sup> T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapyAljawharah Alrubayyi, Anucha Preechanukul, Yinru Zhang, et al.
JHEP Reports : Innovation in Hepatology|October 24, 2025
Corrigendum to "Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response" [J Hepatol (2025) 101382]Douglas L Fink, David Etoori, Robert Hill, et al.
The Journal of Experimental Medicine|December 21, 2012
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletionDimitra Peppa, Upkar S Gill, Gary Reynolds, et al.
Gut|January 6, 2021
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis BValentina Svicher, Romina Salpini, Lorenzo Piermatteo, et al.
The Lancet Regional Health. Europe|June 10, 2026
From targets to real world impact: a review of models of care for chronic HBV and HCV in EuropeCamila A Picchio, Aina Nicolàs, Erika Duffell, et al.
Scientific Reports|July 19, 2017
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosisHarsimran D Singh, Itziar Otano, Krista Rombouts, et al.
The Journal of Clinical Investigation|August 10, 2018
Circulating and intrahepatic antiviral B cells are defective in hepatitis BAlice R Burton, Laura J Pallett, Laura E McCoy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 30, 2016
T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance SystemWei-Chen Huang, Nicholas J Easom, Xin-Zi Tang, et al.
Pageof 6